SunWay Biotech , Ltd. Overview
Valuation check: 1271.TWO's ROE is 5.46%, below the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow5.46%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for 1271.TWO is 5.46%. That is below the sector sector average of 11.64%. Investors often review this figure alongside SunWay Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 1271.TWO currently prints 5.46% for ROE, while the sector average sits near 11.64%. That is roughly 53.0% below the sector mean. Large gaps often invite a closer look at SunWay Biotech , Ltd.'s growth, margins, and balance sheet.
Return on Equity shows how effectively SunWay Biotech , Ltd. converts resources into returns. At 5.46%, 1271.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 1271.TWO's ROE (5.46%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
